The health state of France before COVID-19 pandemic between 1990 and 2019: an analysis of the Global Burden of Disease study 2019
| dc.rights.license | open | en_US |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | FRANCIS-OLIVIERO, Florence | |
| dc.contributor.author | CONSTANTINOU, Panayotis | |
| dc.contributor.author | HANEEF, Romana | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | SCHWARZINGER, Michael | |
| dc.contributor.author | GALLAY, Anne | |
| dc.contributor.author | RACHAS, Antoine | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | ALLA, Francois | |
| dc.date.accessioned | 2024-06-20T12:55:06Z | |
| dc.date.available | 2024-06-20T12:55:06Z | |
| dc.date.issued | 2024-04-01 | |
| dc.identifier.issn | 2666-7762 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/200588 | |
| dc.description.abstractEn | BACKGROUND: France faces nowadays some major challenges regarding its health care system including medically underserved areas, social health inequalities, and hospital pressures. Various indicators and sources of data allow us to describe the health status of a population and, consequently, to assess the impact of these challenges. We assessed the burden of diseases before COVID-19 in France in 2019 and its evolution from 1990 to 2019, and compared it with Western European countries. METHODS: We used specific Global Burden of Diseases (GBD) metrics: socio-demographic index (SDI), life expectancy (LE), healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) with their 95% uncertainty interval (95% UI). We compared French age-standardized metrics to those for other Western European Countries for both sexes and also between 1990 and 2019. We also described the specific causes of these different metrics. FINDINGS: We observed for life expectancy at birth in France a trend to an improvement over time from 77.2 (95% UI: 77.2-77.3) years in 1990 to 82.9 (82.7-83.1) in 2019, which represented the seventh highest life expectancy among 23 Western European countries. HALE at birth in France increased from 67.0 (64.0-69.7) to 71.5 (68.1-74.5), which represented the fourth highest HALE among 23 Western European countries. In France, the total number of DALY per 100.000 population tended to decrease from 25,192 (22,374-28,351) in 1990 to 18,782 (16,408-21,920) in 2019. As compared to other European countries, the burden due to cardiovascular diseases was lower. Neoplasms and cardio-vascular diseases were the two leading causes of YLLs. Mental and musculoskeletal disorders were the two leading causes of YLDs. INTERPRETATION: Overall, these results highlight a clear trend of improvement in the health status in France with certain differences between western European countries. The health policy makers need to devise interventional strategies to reduce the burden of diseases and injuries, with specific attention to causes such as cancers, cardiovascular diseases, mental health and musculoskeletal disorders. FUNDING: Bill & Melinda Gates Foundation. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject.en | France | |
| dc.subject.en | Western Europe | |
| dc.subject.en | “Global Burden of disease” evolution | |
| dc.title.en | The health state of France before COVID-19 pandemic between 1990 and 2019: an analysis of the Global Burden of Disease study 2019 | |
| dc.title.alternative | Lancet Reg Health Eur | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.lanepe.2024.100848 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 38803633 | en_US |
| bordeaux.journal | The Lancet Regional Health - Europe | en_US |
| bordeaux.page | 100848 | en_US |
| bordeaux.volume | 39 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | PHARES_BPH | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Bill and Melinda Gates Foundation | en_US |
| bordeaux.identifier.funderID | Caisse nationale de l'Assurance Maladie | en_US |
| bordeaux.identifier.funderID | Fondation Mérieux | en_US |
| bordeaux.identifier.funderID | Assistance Publique - Hôpitaux de Paris | en_US |
| hal.identifier | hal-04618889 | |
| hal.version | 1 | |
| hal.date.transferred | 2024-06-20T12:55:10Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=The%20Lancet%20Regional%20Health%20-%20Europe&rft.date=2024-04-01&rft.volume=39&rft.spage=100848&rft.epage=100848&rft.eissn=2666-7762&rft.issn=2666-7762&rft.au=FRANCIS-OLIVIERO,%20Florence&CONSTANTINOU,%20Panayotis&HANEEF,%20Romana&SCHWARZINGER,%20Michael&GALLAY,%20Anne&rft.genre=article |
